Gene Query: MGST1

Dataset Description Geneva Score
Role of CD133 molecule in WNT response and renal repair 149.21
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 83.19
G-quadruplex structures mark human regulatory chromatin 76.64
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 70.98
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 68.88
Expression by CD133+ cells isolated from the adult human exocrine pancreas 68.42
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 64.53
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 64.53
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 62.2
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 56.49
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 54.03
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 52.5
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 50.35
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 46.3
RNA-seq data from human lymphoma cell lines 46.13
ChIP-seq and RNA-seq from human lymphoma cell lines 46.13
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 44.24
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 44.16
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 43.21
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 42.83
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 42.83
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 42.51
METTL3 promotes translation in human cancer cells 42.3
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 41.78
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 40.77
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 39.92
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 39.92
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 39.41
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 39.18
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 39.14
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 37.64
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 37.64
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 37.61
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 36.96
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 36.36
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 36.2
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 35.58
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 35.19
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 34.24
Identification of Nrf2 regulated genes by RNA sequencing 33.83
Nrf2 regulated genes in A549 cells 33.83
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 33.65
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 33.53
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 32.81
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 32.8
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 32.59
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 32.26
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 32.26
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 31.48
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 31.38
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 31.37
Nonpregnant and term pregnant human myometrial tissues 31.37
Effect of Hotair overexpression in human breast cancer cell lines 31.05
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 30.99
Identifying the molecular mode of action of itraconazole in colorectal cancer 30.57
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 30.35
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 30.03
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 29.78
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 29.51
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 29.35
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 29.32
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 29.32
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 29.01
Nucleoporin-mediated regulation of cell identity genes 28.8
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 28.73
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 28.47
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 28.41
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 28.31
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 28.31
Disruption of the exocyst induces podocyte loss and dysfunction 27.85
Pharmacologic inhibition of STAT5 in AML 27.54
The Genomic Landscape of Atypical Fibroxanthoma 26.95
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 26.93
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 26.79
RNA-seq analysis of RALD iPSCs after in vitro differentiation 26.77
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 26.62
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 26.33
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 26.33
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 26.18
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 26.18
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 25.96
The effect of PPARG inhibition on human angiomyolipoma cells 25.43
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 25.26
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 24.88
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 24.69
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 24.45
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 24.27
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 23.92
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 23.86
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 23.8
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 23.79
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 23.74
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 23.68
DAOY-Notch1/Notch2 knockout: transcriptome comparison 23.62
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 23.6
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 23.59
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 23.56
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 23.56
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 23.42
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 23.39
GATA3-mediated chromatin reprogramming in breast cancer cells 23.24
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 23.13
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 22.9
WRN knockout effects upon gene expression in SW48 and OVK18 22.83
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 22.82
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 22.82
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 22.68
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 22.51
Differentially expressed vascular development genes for iPSC-ECs from CDI 22.45
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 22.38
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 22.09
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 22.01
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 21.75
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 21.72
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 21.72
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 21.59
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 21.47
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 21.42
Investigation about fibroblasts of different origins in culture 21.35
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 21.33
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 21.33
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 21.23
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 21.14
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 21.14
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 21.13
NHLRC1 re-expression in cancer cells 20.79
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 20.61
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 20.61
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 20.56
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 20.22
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 20.22
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 20.21
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 20.2
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 20.05
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 19.86
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 19.63
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 19.37
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 19.37
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 19.36
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 19.34
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 19.28
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 19.17
CD86 regulates a pro-survival signal in myeloma cells 19.01
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 18.97
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 18.96
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 18.95
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 18.86
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 18.66
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 18.66
Non-coding regions are the main source of tumor-specific antigens 18.64
Non-coding regions are the main source of tumor-specific antigens [human] 18.64
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 18.52
A practical evaluation of alignment algorithms for RNA variant calling analysis 18.49
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 18.48
Transcriptome analysis of kidney organoids 18.43
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 18.35
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 18.29
Genome-wide functional assessment of enhancer activities in the human genome 18.29
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 18.15
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 18.06
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 18.04
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 18.01
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 17.98
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 17.91
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 17.75
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 17.75
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 17.71
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 17.6
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 17.59
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 17.41
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 17.41
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 17.34
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 17.2
An RNA-centric dissection of host complexes controlling flavivirus infection 17.2
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 17.1
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 17.06
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 17.06
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 17.05
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 17.05
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 17.05
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 16.76
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 16.73
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 16.7
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 16.66
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 16.5
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 16.48
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 16.48
Generation of trichogenic adipose-derived stem cells by expression of three factors 16.46
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 16.44
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 16.43
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 16.43
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 16.41
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 16.41
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 16.38
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 16.34
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 16.34
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 16.24
TGF-β regulation of miRNA expression in pancreatic cancer 16.11
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 16.0
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 16.0
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 15.93
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 15.93
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 15.84
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 15.84
RNA-Seq with and without RNase treatment in PCa cell lines 15.83
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 15.81
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 15.79
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 15.74
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 15.67
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 15.64
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 15.62
Transcriptome analysis of virus infected tissues 15.59
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 15.56
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 15.53
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 15.51
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 15.48
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 15.48
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 15.45
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 15.41
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 15.4
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 15.27
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 15.22
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 15.22
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 15.14
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 15.11
Cerebellar differentiation in Ataxia-Telangiectasia 14.98
Gene expression profiling of KSHV-infected periodontal ligament cells 14.97
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 14.97
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 14.92
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 14.92
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 14.89
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.85
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 14.84
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 14.79
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 14.77
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 14.69
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 14.63
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 14.63
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 14.54
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 14.5
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 14.48
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 14.47
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 14.45
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 14.41
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 14.41
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 14.38
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 14.31
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 14.28
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 14.21
Global expression profiles in cardiac progenitor cells generated by ISX-9 14.13
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 14.13
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 14.12
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 14.12
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 14.12
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 14.1
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 14.07
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 14.05
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 14.03
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 14.02
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 13.97
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 13.93
Transcriptome of human white and brown adipose tissue biopsies 13.91
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 13.86
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 13.86
Neurofibroma 13.83
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 13.83
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 13.78
Gene expression profile of multiple myeloma cell lines treated with CB-5083 13.71
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 13.63
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 13.6
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 13.5
RNA sequencing analysis of human embryonic stem cells and axial progenitors 13.48
Generating Patterned Kidney Organoids for Studying Development and Diseases 13.47
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 13.35
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 13.35
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 13.26
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 13.24
Changes in human endometrial gland transcriptome over the window of implantation 13.21
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 13.19
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 13.18
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 13.12
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 13.06
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 13.04
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 13.04
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 12.96
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 12.93
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 12.92
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 12.88
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 12.73
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 12.73
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 12.56
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 12.56
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 12.56
Transcriptional landscape changes during human embryonic stem cell derivation 12.48
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 12.27
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 12.22
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 12.13
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 12.13
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 12.11
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 12.11
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 12.1
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 12.07
Gene expression profile difference among renal location in a stone former 11.97
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 11.95
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 11.95
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 11.9
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 11.85
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 11.78
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 11.72
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 11.61
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 11.53
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 11.53
Human optic chiasm from healthy controls and multiple sclerosis patients 11.42
Multiple sclerosis and EAE 11.42
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 11.28
Exogenous rescue of KLHL9 in SF210 cell line 11.28
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 11.18
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.17
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 11.15
Endometrial transcriptome and PGR cistrome in cycling fertile women 11.15
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 10.92
FGF2 regulation of gene expression in stable inducible Neurons 10.91
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 10.75
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 10.75
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 10.58
Role of FGFR1 in neuronal devlopment 10.48
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 10.38
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 10.38
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 10.37
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 10.33
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 10.19
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 10.18
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 10.13
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 10.04
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 9.98
hnRNP C is a key regulator of protein synthesis in mitosis 9.9
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 9.83
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 9.82
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 9.77
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 9.74
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 9.66
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 9.61
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 9.57
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 9.49
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 9.43
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.3
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.3
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 9.28
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 9.15
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 9.01
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 8.98
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 8.97
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 8.97
Transcriptome of Stabilin-1 siRNA transfected human monocytes 8.89
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 8.88
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 8.83
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 8.8
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 8.79
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 8.76
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 8.72
Gene expression of thyroid cancer cell lines 8.69
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 8.49
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 8.48
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 8.2
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 8.17
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 7.85
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 7.67
The transcriptome of Kawasaki Disease arteritis 7.66
Reprogrammed myeloid cell transcriptomes in NSCLC 7.65
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 7.52
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 7.49
Gene expression patterns define the hepatocyte-like cells derived by different strategies 7.42
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 7.42
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 7.4
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 7.35
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.32
Impact on erythroid progenitor type on erythroid differntiation 7.25
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 7.24
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 7.23
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 7.22
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 7.2
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 7.13
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.08
High-throughput sequencing of PROMPT-enriched samples. 7.06
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  6.99
Trascriptome of thyroid cancer-induced macrophages 6.98
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.94
KLF6-dependent transcription in renal cancer cells 6.75
HEK293 TFAM Knockout Expression Study 6.75
Anti-inflammatory effect of indoleacrylic acid (IA) 6.74
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 6.62
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.42
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 6.38
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 6.34
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 6.28
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 6.18
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 6.18
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 6.09
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 6.09
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 6.09
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 6.03
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 5.9
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 5.84
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 5.68
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 5.65
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 5.62
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 5.6
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 5.55
The MEF2B Regulatory Network - RNA-seq data 5.46
The MEF2B Regulatory Network 5.46
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 5.44
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 5.4
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 5.4
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 5.4
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 5.38
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 5.38
A single cell reference map for human blood and tissue T cell activation 5.17
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 5.14
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 5.14
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 5.09
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.04
Persistence of stem cell metabolism in cancers as a failure of differentiation 4.87
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 4.74
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.7
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 4.45
Hepatocyte maturation 4.36
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.34
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 4.07
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 4.07
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 3.95
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.87
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.87
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.76
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 3.73
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 3.56
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.55
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.43
Efficient derivation of microglia-like cells from human pluripotent stem cells 3.4
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.38
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.38
Identification of differentially expressed genes between senescence and senescence bypass cells 3.29
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 3.17
MRTF activates TEAD-YAP target gene expression 3.07
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 3.04
Transcriptomic analysis of frontal fibrosing alopecia 2.87
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.63
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.59
Differential gene expression in Jagged1 treated human dental pulp cells. 2.58
Preclinical model of obesity and ER-positive breast cancer 2.58
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.56
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.56
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.53
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.53
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.46
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.46
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.43
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.4
Loss of endometrial plasticity in recurrent pregnancy loss 2.4
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.33
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 2.22
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.2
Finding missing proteins from epigenetically manipulated human cells 2.02
JAK dependent survival of ALK- ALCL 1.98
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.9
RNA seq_PDX2_SHP099 1.89
hNSCs siRNA NOVA2 1.82
Effects of rFVIIIFc on human macrophages 1.67
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.57
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.45
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 1.31
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.28
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.26
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.21
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 1.13
Gene expression profiling in metabolically heterogeneous human lung tumors 1.1
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.06
RNA-Seq and expression data from human adipose tissue 0.96
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.96
Gene expression profile of human iPSC-derived nephron progenitor cells 0.95
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.95
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.86
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.72
FOXP2's impact on the primate transcriptome 0.59
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.57
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.57
MHC Transcriptomic landscape at haplotype-specific resolution 0.54
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.44
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.38
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.32
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.32
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 0.26
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.26
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.25
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.25
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.15
mRNA sequencing of oropharyngeal cancer cell lines 0.09
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.09
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.07
RNA-seq of CD33 KO and control HSPCs 0.03
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation